未登录Glimepiride and Metformin Fixed-Dose Combination (FDC) along with Metformin plus Dapagliflozin plus Sitagliptin FDC in T2DM Patients with High Risk for Cardiovascular Disease: GRACE-CVD Study格列美脲和二甲双胍固定剂量组合(FDC)以及二甲双胍联合达格列净联合西格列汀FDC在具有心血管疾病高风险的2型糖尿病患者中的应用:GRACE-CVD研究
Murthy, L. S.; Jain, Anuj; Katakam, Lavanya; Bhattacharyya, Arpandev; Sait, K. N.; Chavan, Mahesh; Chitale, Manoj; Bhojane, Sonali; Sardar, Ashish; Prasad, Ashish
分享
收藏Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases高血压控制之外的益处:心血管疾病预防的当前与演变治疗策略
Taraphder, Abhijit; Almeida, Alan; Dani, Sameer; Bansal, Sandeep; Balagopalan, Jayagopal Pathiyil; Bhattacharyya, Arpandev; Zargar, Abdul Hamid; Chowdhury, Subhankar; Kale, Shailaja; Deka, Nilakshi; Jiwane, Dinesh; Jain, Sanjay
分享
收藏Glimepiride & metformin FDC along with metformin plus dapagliflozin plus sitagliptin FDC in T2DM patients with high-risk CKD -Indian real world evidence study: GRACE CKD格列美脲 & 二甲双胍固定剂量复方制剂,以及二甲双胍联合达格列净联合西格列汀固定剂量复方制剂在伴有高风险慢性肾脏病(CKD)的2型糖尿病(T2DM)患者中的印度真实世界证据研究:GRACE CKD研究。
Murthy, L. Sreenivasa; Jain, Anuj; Katakam, Lavanya; Bhattacharyya, Arpandev; Sait, Naseem; Chavan, Mahesh; Chitale, Manoj; Bhojane, Sonali; Sardar, Ashish; Prasad, Ashish
分享
收藏
分享
收藏
分享
收藏